Atlas Trials

Therapeutic Strategies in Acromegalic Subjects Treated With Lanreotide 120mg

Clinical trial NCT02698384 · TERMINATED

Trial details

NCT number
NCT02698384
Sponsor
Ipsen
Status
TERMINATED
Study type
OBSERVATIONAL
Acromegaly
Start date
2016-01-01
Primary completion
2016-01-01
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.